Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …

Science in the UK will have to focus on contractually-based research in the future as pharma’s R&D presence in the …
The government has revised the research contracting process in a bid to streamline research between pharma and biotech companies, universities …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

